Form 4: KalVista Pharmaceuticals Officer Paul K. Audhya Reports Stock Transactions
SEC Form 4 Filing
Paul K. Audhya, Chief Medical Officer of KalVista Pharmaceuticals, reports the vesting and sale of shares to cover tax obligations.
Summary
- Paul K. Audhya, Chief Medical Officer of KalVista Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
- On May 17, 2025, Audhya acquired 6,447 shares of common stock through the vesting of restricted stock units (RSUs) and performance stock units (PSUs).
- Also on May 17, 2025, 2,419 RSUs and 4,028 PSUs were settled.
- On May 19, 2025, Audhya sold 2,776 shares at a price of $11.8428 per share to cover tax withholding obligations related to the vesting of RSUs and PSUs.
- Following these transactions, Audhya directly owns 106,611 shares of KalVista Pharmaceuticals common stock, 9,675 RSUs related to one vesting schedule and 8,056 RSUs related to another vesting schedule.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company officer. It doesn't inherently convey positive or negative sentiment, as it's a standard regulatory filing.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares, but it is primarily related to tax obligations of the reporting person.
Key Dates
| Date | Description |
|---|---|
| August 17, 2022 | Vesting Commencement Date for 1/16th of RSUs, vesting quarterly thereafter. |
| November 17, 2022 | Vesting Commencement Date for 1/12th of RSUs, vesting quarterly thereafter. |
| May 17, 2025 | Acquisition of 6,447 shares through RSU/PSU vesting; settlement of 2,419 and 4,028 RSUs. |
| May 19, 2025 | Sale of 2,776 shares at $11.8428 to cover tax obligations. |
| May 20, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Sale, Stock Vesting, KalVista Pharmaceuticals, Audhya, RSU, PSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.